Pellicano R, Strona S, Simondi D, Reggiani S, Pallavicino F, Sguazzini C, Bonagura A G, Rizzetto M, Astegiano M
University Department of Gastro-Hepathology, Molinette Hospital, Turin, Italy.
Minerva Gastroenterol Dietol. 2009 Sep;55(3):227-35.
Because of the multifactorial pathogenesis of functional dyspepsia, strategies alternative to antacid therapy are being sought for treating the disorder. This prospective study evaluated the benefit of treatment with a dietary integrator composed of sodium alginate, sodium bicarbonate, bromelin and essential oils.
The study population included 53 consecutive patients (22 males, 31 females; mean age, 54+/-2.5 years) with functional dyspepsia and negative for Helicobacter pylori infection. The patients were categorized into four subgroups according to predominant symptom: ulcer-like dyspepsia, motility-like dyspepsia, reflux-like dyspepsia, and nonspecific dyspepsia. All received TUBES gastro (0.80 g oral tablets bid) for a minimum of 3 months (range, 3-11). Treatment efficacy was measured by means of a Visual Analogue Scale (VAS).
Two patients were lost to follow-up; of the remaining 51 patients who completed the study, 35 (68%) showed an improvement in VAS score. The difference in scores between the initial and the final visit was -1.9+/-2.1 cm (range, -6 to +3), or 23.8+/-40.8% (range, -150% to 100%) compared to the scores at the baseline visit (P=0.0001).
The study results indicate that in the short term TUBES gastro can significantly improve dyspeptic symptoms in dyspeptic patients negative for H. pylori infection through the synergistic action of its components: alginate buffers gastric acid; bicarbonate helps to eliminate gas and rebalance pH; essential oils regulate motility; and bromelin stimulates enzymatic activity.
由于功能性消化不良的发病机制具有多因素性,人们正在寻找抗酸治疗以外的策略来治疗这种疾病。本前瞻性研究评估了由海藻酸钠、碳酸氢钠、菠萝蛋白酶和精油组成的饮食整合剂的治疗效果。
研究人群包括53例连续的功能性消化不良患者(22例男性,31例女性;平均年龄54±2.5岁),幽门螺杆菌感染检测为阴性。根据主要症状将患者分为四个亚组:溃疡样消化不良、动力样消化不良、反流样消化不良和非特异性消化不良。所有患者均接受TUBES gastro(口服片剂0.80 g,每日两次)治疗至少3个月(范围3 - 11个月)。通过视觉模拟量表(VAS)测量治疗效果。
两名患者失访;在完成研究的其余51例患者中,35例(68%)的VAS评分有所改善。初始访视和最终访视之间的评分差异为-1.9±2.1 cm(范围-6至+3),与基线访视时的评分相比为23.8±40.8%(范围-150%至100%)(P = 0.0001)。
研究结果表明,短期内TUBES gastro可通过其成分的协同作用显著改善幽门螺杆菌感染阴性的消化不良患者的消化不良症状:海藻酸盐缓冲胃酸;碳酸氢盐有助于消除气体并重新平衡pH值;精油调节动力;菠萝蛋白酶刺激酶活性。